Scarica l'app Stockscreener
12.64
1.02%
-0.13
Dopo l'orario di chiusura:
12.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.77
Aprire:
$12.85
Volume 24 ore:
1.08M
Relative Volume:
0.51
Capitalizzazione di mercato:
$854.08M
Reddito:
$796.00M
Utile/perdita netta:
$-136.49M
Rapporto P/E:
-6.0478
EPS:
-2.09
Flusso di cassa netto:
$-64.24M
1 W Prestazione:
+3.78%
1M Prestazione:
+5.95%
6M Prestazione:
-38.70%
1 anno Prestazione:
-72.18%
Intervallo 1D:
$12.55
$13.10
Intervallo di 1 settimana:
$12.21
$13.52
Portata 52W:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Confronta TNDM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.64 | 862.86M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
133.89 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.06 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
371.22 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.74 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.66 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Iniziato | Oppenheimer | Outperform |
| 2025-08-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Downgrade | Citigroup | Neutral → Sell |
| 2025-06-16 | Iniziato | Truist | Hold |
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2025-03-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-03-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
18% Of This Tandem Diabetes Care Insider's Holdings Were Sold - 富途牛牛
Diabetes Care Market is Set to Boom: Strategic Outlook and Market Dynamics with Key Players like | Medtronic, Abbott, Pumps It, Inc. - industrytoday.co.uk
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Did You Suffer Losses in Tandem Diabetes Care, Inc. (TNDM)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire
Levi & Korsinsky Launches Fraud Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders - ACCESS Newswire
Does Tandem Diabetes Care Inc have pricing powerMarket Risk Report & Stepwise Entry and Exit Trade Signals - خودرو بانک
Aug Sectors: Is Tandem Diabetes Care Inc. a strong candidate for buy and holdWeekly Stock Summary & Consistent Income Trade Ideas - خودرو بانک
Aug Summary: Is Tandem Diabetes Care Incs growth already priced inDollar Strength & Weekly Market Pulse Updates - خودرو بانک
Tandem Diabetes Care, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsTNDM - ACCESS Newswire
Growth Report: What is Tandem Diabetes Care Inc.’s valuation compared to sectorJuly 2025 Chart Watch & Comprehensive Market Scan Reports - khodrobank.com
Aug Spikes: Is MacKenzie Realty Capital Inc backed by strong institutional buyingMarket Performance Recap & Long Hold Capital Preservation Plans - khodrobank.com
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Why Tandem Diabetes (TNDM) Stock Is Up Today - TradingView
United States Insulin Pump Market Expansion Driven by Diabetes - openPR.com
Aug Analyst Calls: Should value investors consider Tandem Diabetes Care IncWeekly Trend Recap & Daily Profit Maximizing Tips - خودرو بانک
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels - BioSpace
Sell Signal: Is Tandem Diabetes Care Inc. stock risky to hold nowEarnings Performance Report & Capital Efficient Trade Techniques - خودرو بانک
Market Wrap: Whats the beta of Tandem Diabetes Care Inc stockJuly 2025 Setups & Technical Pattern Alert System - خودرو بانک
Tandem Diabetes (TNDM) Study Highlights Benefits of Control-IQ+ - GuruFocus
Tandem study- adults with type 2 diabetes benefit from automated insulin delivery, regardless of C-peptide levels - MarketScreener
About Us - FinancialContent
Aug Patterns: Does Tandem Diabetes Care Inc. have strong fundamentalsPortfolio Value Report & Reliable Breakout Stock Forecasts - خودرو بانک
Acadian Asset Management LLC Takes Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Value Recap: Will Tandem Diabetes Care Inc stock benefit from M AEarnings Growth Summary & Risk Managed Trade Strategies - خودرو بانک
Earnings Recap: How is Tandem Diabetes Care Inc managing supply chain issues2025 Fundamental Recap & Safe Entry Point Identification - خودرو بانک
Diabetes warning issued over insulin pump error - MSN
Market Trends: Is Tandem Diabetes Care Incs growth already priced inJuly 2025 Pullbacks & Consistent Return Investment Signals - خودرو بانک
Fda Tandem Diabetes Care Issues Correction For Certain TSlim X2 Insulin Pumps - MarketScreener
Analysis Recap: Is Tandem Diabetes Care Inc part of any major indexBond Market & Consistent Profit Trading Strategies - خودرو بانک
Weekly Recap: Is Tandem Diabetes Care Inc forming bullish engulfing patternsJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People” - Yahoo
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | Dow Theory Letters - FinancialContent
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Sees Significant Drop in Short Interest - MarketBeat
Jim Cramer: This Is The Right Time To Buy This Energy Stock - Sahm
Jacobs Levy Equity Management Inc. Cuts Stock Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | FinancialContent - FinancialContent
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM - The Joplin Globe
Edmond DE Rothschild Holding S.A. Makes New $4.84 Million Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | Dow Theory Letters - FinancialContent
What data driven models say about Tandem Diabetes Care Inc.’s future2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Elliott Wave Theory Predicts Pullback in Tandem Diabetes Care Inc.2025 Market Outlook & Technical Confirmation Trade Alerts - beatles.ru
Sessa Capital IM L.P. Acquires Shares of 4,466,307 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
RSI Crosses Above 30 for Tandem Diabetes Care Inc. — Reversal in SightJuly 2025 Intraday Action & Risk Adjusted Buy and Sell Alerts - beatles.ru
TNDM's Analyst Ratings: Oppenheimer Lowers Price Target by 50% | - GuruFocus
Oppenheimer Adjusts Tandem Diabetes Care Price Target to $22 From $44, Maintains Outperform Rating - MarketScreener
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):